Evidence map›Paper›PMID 36013937›Full record

ArticleMicroorganisms2022

A Novel Antimicrobial Metabolite Produced by

Alexander Meene, Christiane Herzer, Rabea Schlüter, Bolatkhan Zayadan, Ruediger Pukall, Peter Schumann, Frieder Schauer, Tim Urich, Annett Mikolasch

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Alexander MeeneInstitute of Microbiology, University Greifswald, Felix-Hausdorff-Straße 8, 17487 Greifswald, Germany.
Christiane HerzerInstitute of Microbiology, University Greifswald, Felix-Hausdorff-Straße 8, 17487 Greifswald, Germany.
Rabea SchlüterImaging Center of the Department of Biology, University Greifswald, Friedrich-Ludwig-Jahn-Str. 15, 17487 Greifswald, Germany.
Bolatkhan ZayadanDepartment of Biotechnology, Al-Farabi Kazakh National University, 71, al-Farabi Ave, Almaty 050040, Kazakhstan.
Ruediger PukallLeibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Inhoffenstrasse 7B, 38124 Braunschweig, Germany.
Peter SchumannLeibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Inhoffenstrasse 7B, 38124 Braunschweig, Germany.
Frieder SchauerInstitute of Microbiology, University Greifswald, Felix-Hausdorff-Straße 8, 17487 Greifswald, Germany.
Tim UrichInstitute of Microbiology, University Greifswald, Felix-Hausdorff-Straße 8, 17487 Greifswald, Germany.ORCID 0000-0002-5718-1354
Annett MikolaschInstitute of Microbiology, University Greifswald, Felix-Hausdorff-Straße 8, 17487 Greifswald, Germany.
Leibniz Institute DSMZ – German Collection of Microorganisms and Cell Cultures · DEAl-Farabi Kazakh National University · KZUniversität Greifswald · DE

Funding

German Academic Exchange Service 50754935German Academic Exchange Service 57525256
6 · The paper itself

Abstract

Four aerobic bacteria with bacteriolytic capabilities were isolated from the brackish water site Strait Uzynaral of Lake Balkhash in Kazakhstan. The morphology and physiology of the bacterial isolates have subsequently been analyzed. Using matrix assisted laser desorption ionization-time of flight mass spectrum and partial 16S rRNA gene sequence analyses, three of the isolates have been identified as

Indexed as

antibioticantimicrobialbacterivoryEscherichia colilipopeptidesMicrococcus luteuspredationPseudomonas putida

Identifiers

PMID36013937
PMCPMC9416454
OpenAlexW4288081084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.